Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1L1 | Q9UHC9 | 10/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | CDC25A | P30304 | 2/20 | 0.53 |
| ▸ | POLA1 | P09884 | 1/20 | 0.53 |
| ▸ | FNTA | P49354 | 2/20 | 0.50 |
| ▸ | FNTB | P49356 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29397341 | 0.90 | NPC1L1 (0.59) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL6391409 | 0.84 | NPC1L1 (0.73) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL6390397 | 0.84 | NPC1L1 (0.73) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL6387174 | 0.84 | NPC1L1 (0.73) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL7124642 | 0.84 | NPC1L1 (0.73) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL25337296 | 0.84 | NPC1L1 (0.64) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL29354605 | 0.83 | NPC1L1 (0.72) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL23452797 | 0.83 | NPC1L1 (0.67) | NPC1L1MEN1USP2LMNATP53 | |
| Cholestan-3Beta,5Alpha,6Beta-Triol SCHEMBL25277367 | 0.82 | NPC1L1 (1.00) | NPC1L1MEN1USP2LMNATP53 | |
| Cholestan-3Beta,5Alpha,6Beta-Triol SCHEMBL14490136 | 0.82 | NPC1L1 (1.00) | NPC1L1MEN1USP2LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665733-A1 | AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 | Bristol-Myers Squibb Company (US) | 2025-12-24 | — | — | EP | claimed |
| WO-2024173323-A1 | AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-08-22 | — | — | WO | claimed |
| CN-117894369-A | Screening method of plant environment adaptability candidate genes based on selective elimination SNP guidance | 华南农业大学 | 2024-04-16 | — | — | CN | claimed |
| CN-113591579-B | Significance target detection method based on attention mechanism convolutional neural network | 河北师范大学 | 2024-02-13 | — | — | CN | claimed |
| CN-115768892-A | Herpes zoster vaccine comprising a TLR9 agonist | 戴纳瓦克斯技术公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115627270-A | Label-free ratio type malachite green luminescence aptamer biosensor | 中国农业大学 | 2023-01-20 | — | — | CN | claimed |
| CN-115040532-A | Treatment of cancer using TLR9 agonists and checkpoint inhibitors | 伊黛拉制药有限公司 | 2022-09-13 | — | — | CN | claimed |
| EP-4003955-A1 | INHIBITORS OF HUMAN ATGL | Karl-Franzens-Universität Graz (AT) | 2022-06-01 | — | — | EP | claimed |
| CN-114444689-A | Transformer temperature detection and analysis method | 国网山东省电力公司德州供电公司 | 2022-05-06 | — | — | CN | claimed |
| CN-114089046-A | ZPW-2000 series track circuit compensation capacitance parameter estimation method and device | 四川高新轨道交通产业技术研究院 | 2022-02-25 | — | — | CN | claimed |
| CN-116874755-B | Composite titanium catalyst and preparation method and application thereof | 浙江糖能科技有限公司 | 2026-05-22 | — | — | CN | disclosed |
| US-20260135023-A1 | HIGH-COERCIVITY AND HIGH-REMANENCE NdFeB MAGNET AND PREPARATION METHOD | BEIJING ZHONG KE SAN HUAN HI TECH CO LTD (CN) | 2026-05-14 | — | — | US | disclosed |
| US-20260094743-A1 | NdFeB MAGNET | NINGBO KONIT IND INC (CN) | 2026-04-02 | — | — | US | disclosed |
| US-20260083856-A1 | THIAZOLIDINE LINKERS FOR PROTEIN-DRUG CONJUGATES AND USES THEREOF | SCHERER TECHNOLOGIES LLC R P (US) | 2026-03-26 | — | — | US | disclosed |
| US-12571026-B2 | Probes for improved melt discrimination and multiplexing in nucleic acid assays | LUMINEX CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| CN-114349368-A | Chemically strengthened glass and glass for chemical strengthening | ＡＧＣ株式会社 | 2022-04-15 | — | — | CN | disclosed |
| CN-114315133-A | Chemically strengthened glass and glass for chemical strengthening | ＡＧＣ株式会社 | 2022-04-12 | — | — | CN | disclosed |
| CN-110892296-B | Composition for forming infrared-transmitting film, method for forming infrared-transmitting film, protective plate for display device, and display device | JSR株式会社 | 2022-03-22 | — | — | CN | disclosed |
| EP-3967771-A1 | PROBES FOR IMPROVED MELT DISCRIMINATION AND MULTIPLEXING IN NUCLEIC ACID ASSAYS | Luminex Corporation (US) | 2022-03-16 | — | — | EP | disclosed |
| US-11261481-B2 | Probes for improved melt discrimination and multiplexing in nucleic acid assays | LUMINEX CORPORATION (US) | 2022-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260094743-A1 | NdFeB MAGNET | TPR, NDC1, TCP1 | NPC1L1 1596/4885MEN1 468/4885USP2 3527/4885 |
| US-20260083856-A1 | THIAZOLIDINE LINKERS FOR PROTEIN-DRUG CONJUGATES AND USES THEREOF | BRWD1, TMIGD3, TXNL1 | NPC1L1 987/4885MEN1 2536/4885USP2 2115/4885 |
| US-20260135023-A1 | HIGH-COERCIVITY AND HIGH-REMANENCE NdFeB MAGNET AND PREPARATION METHOD | LBR, HBB, MYB | NPC1L1 1245/4885MEN1 1057/4885USP2 2979/4885 |
| US-12571026-B2 | Probes for improved melt discrimination and multiplexing in nucleic acid assays | CPSF6, CPSF1, NUDT21 | NPC1L1 4664/4885MEN1 1537/4885USP2 2788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.